<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03150732</url>
  </required_header>
  <id_info>
    <org_study_id>000087273</org_study_id>
    <nct_id>NCT03150732</nct_id>
  </id_info>
  <brief_title>Systemic Nalbuphine Versus Intravenous Regional Anesthesia</brief_title>
  <official_title>Comparison of Systemic Nalbuphine Versus Intravenous Regional Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of systemic nalbuphine versus intravenous regional anesthesia in patients
      undergoing hand surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 23, 2018</start_date>
  <completion_date type="Anticipated">December 11, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 10, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two groups</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Visual Analogue Scale (VAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First analgesic request</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Diclofenac analgesic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortisol level</measure>
    <time_frame>Preoperative and at 4 hours after skin incision</time_frame>
    <description>Level of cortisone in blood (nmol/L)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">106</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Systemic nalbuphine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>53 patients will receive nalbuphine systemically</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local nalbuphine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>53 patients will receive nalbuphine with local intravenous regional anesthesia (IVRA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Systemic nalbuphine</intervention_name>
    <description>Patients will receive systemic nalbuphine 10 mg</description>
    <arm_group_label>Systemic nalbuphine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Local nalbuphine</intervention_name>
    <description>Patients will receive local nalbuphine 10 mg</description>
    <arm_group_label>Local nalbuphine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective unilateral hand surgery.

        Exclusion Criteria:

          -  Patient refusal.

          -  Allergy to study medications

          -  Body mass index &gt; 35 kg/ m2

          -  Patients with sickle cell or Reynaud diseases

          -  Patients with a history of psychiatric illness or on chronic opioids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eman Ismail</last_name>
    <phone>+20882413201</phone>
    <email>emanismail97@gmail.com</email>
  </overall_contact>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2017</study_first_submitted>
  <study_first_submitted_qc>May 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2017</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohamed Bakri</investigator_full_name>
    <investigator_title>Professor of anesthesia &amp; ICU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Nalbuphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

